RESUMO
BACKGROUND/AIM: Acute myeloid leukemia (AML) is a myeloproliferative neoplasm marked by abnormal clonal expansion of hematopoietic progenitor cells, displaying karyotypic aberrations and genetic mutations as prognostic indicators. The World Health Organization (WHO) and the European LeukemiaNet guidelines categorize BCR::ABL1 p190+ AML as high risk. This study explored the identification of the increased incidence of BCR::ABL1 p190+ in our AML population. PATIENTS AND METHODS: This study included 96 AML patients stratified according to WHO guidelines. Subsequently, patients were screened for genetic abnormalities, such as BCR::ABL1 p 190+, PML::RARA, RUNX1::RUNX1T1, and CBFB::MYH11 by quantitative reverse transcription polymerase chain reaction (RT-qPCR) analysis. RESULTS: Among 96 AML patients, 36 displayed BCR::ABL1 p190+, overcoming the expected global incidence. Age variations (19 to 78 years) showed no significant laboratory differences between BCR::ABL1 p190+ and non-BCR::ABL p190+ cases. The overall survival analysis revealed no statistically significant differences among the patients (p=0.786). CONCLUSION: The analyzed population presented a higher frequency of BCR::ABL1 p190+ detection in adult AML patients when compared to what is described in the worldwide literature. Therefore, more studies are needed to establish the reason why this incidence is higher and what the best treatment approach should be in these cases.
Assuntos
Proteínas de Fusão bcr-abl , Leucemia Mieloide Aguda , Humanos , Adulto , Leucemia Mieloide Aguda/genética , Leucemia Mieloide Aguda/diagnóstico , Leucemia Mieloide Aguda/mortalidade , Pessoa de Meia-Idade , Masculino , Feminino , Proteínas de Fusão bcr-abl/genética , Idoso , Prognóstico , Adulto Jovem , MutaçãoRESUMO
BACKGROUND/AIM: The relevance of cytogenetic markers as prognostic risk factors has been demonstrated in a vast number of studies, with many prognostication tools utilizing these factors to determine treatment approaches. Patients aged above 60 years represent an important subgroup of acute myeloid leukemia (AML) patients, especially because they usually exhibit a poorer cytogenetic landscape and are less suitable for intensive treatments. The importance of evaluating prognostic parameters in AML, especially in low-income countries, prompted an investigation into CD38 expression and its effects. PATIENTS AND METHODS: Medical records of AML patients aged above 60 years from three hospitals in Brazil's northwest region were analyzed. A total of 67 patients were evaluated in terms of overall survival and factors predicting worse outcomes. The risk stratification was performed based on the European LeukemiaNet 2022 guidelines. The analysis of immunophenotyping markers was conducted using multi-parametric flow cytometry. RESULTS: The overall survival of CD38-positive AML patients was higher than that of patients with CD38-negative AML, with survival rates of 15.6 months versus 4 months, respectively (p-value=0.026). The impact of CD38 positivity was relevant also in multivariable Cox proportional hazards regression, demonstrating a positive effect on overall survival, with a hazard ratio of 0.33 (95%CI=0.13-0.79; p-value=0.014). CONCLUSION: Expression of CD38 in patients with AML was associated with better overall survival and serves as a relevant predictor of improved outcome in patients aged above 60 years.
Assuntos
ADP-Ribosil Ciclase 1 , Biomarcadores Tumorais , Imunofenotipagem , Leucemia Mieloide Aguda , Humanos , Leucemia Mieloide Aguda/imunologia , Leucemia Mieloide Aguda/mortalidade , Idoso , ADP-Ribosil Ciclase 1/metabolismo , Feminino , Masculino , Prognóstico , Pessoa de Meia-Idade , Biomarcadores Tumorais/genética , Idoso de 80 Anos ou mais , Glicoproteínas de Membrana/metabolismoRESUMO
Leukemias are hematological neoplasms characterized by dysregulations in several cellular signaling pathways, prominently including the PI3K/AKT/mTOR pathway. Since this pathway is associated with several important cellular mechanisms, such as proliferation, metabolism, survival, and cell death, its hyperactivation significantly contributes to the development of leukemias. In addition, it is a crucial prognostic factor, often correlated with therapeutic resistance. Changes in the PI3K/AKT/mTOR pathway are identified in more than 50% of cases of acute leukemia, especially in myeloid lineages. Furthermore, these changes are highly frequent in cases of chronic lymphocytic leukemia, especially those with a B cell phenotype, due to the correlation between the hyperactivation of B cell receptors and the abnormal activation of PI3Kδ. Thus, the search for new therapies that inhibit the activity of the PI3K/AKT/mTOR pathway has become the objective of several clinical studies that aim to replace conventional oncological treatments that have high rates of toxicities and low specificity with target-specific therapies offering improved patient quality of life. In this review we describe the PI3K/AKT/mTOR signal transduction pathway and its implications in leukemogenesis. Furthermore, we provide an overview of clinical trials that employed PI3K/AKT/mTOR inhibitors either as monotherapy or in combination with other cytotoxic agents for treating patients with various types of leukemias. The varying degrees of treatment efficacy are also reported.
RESUMO
Effective therapies for multidrug-resistant (MDR) microorganisms, especially Gram-negative bacteria, are becoming rare. Also, solid-organ transplant recipients are at high risk of MDR Gram-negative bacilli infection. Urinary tract infections are the most frequent bacterial infections in kidney transplant recipients and are an important cause of mortality after renal transplantation. We describe a case of complicated urinary tract infection in a kidney transplant patient due to extensively drug-resistant (XDR) K. pneumoniae treated successfully with a regimen comprising a combination of chloramphenicol and ertapenem. We do not recommend chloramphenicol as a first-line choice for treating complicated urinary tract infections. Still, we believe it is an alternative for infections caused by MDR and/or XDR pathogens in renal transplant patients, as other options are nephrotoxic.
Assuntos
Transplante de Rim , Infecções Urinárias , Humanos , Antibacterianos/uso terapêutico , Antibacterianos/farmacologia , Cloranfenicol/farmacologia , Transplante de Rim/efeitos adversos , Klebsiella pneumoniae , Farmacorresistência Bacteriana Múltipla , Bactérias Gram-Negativas , Infecções Urinárias/diagnóstico , Infecções Urinárias/tratamento farmacológicoRESUMO
OBJECTIVE: The coronavirus disease 2019 (COVID-19) pandemic has caused a global health crisis and may have affected healthcare-associated infection (HAI) prevention strategies. We evaluated the impact of the COVID-19 pandemic on HAI incidence in Brazilian intensive care units (ICUs). METHODS: In this ecological study, we compared adult patients admitted to the ICU from April through June 2020 (pandemic period) with the same period in 2019 (prepandemic period) in 21 Brazilian hospitals. We used the Wilcoxon signed rank-sum test in a pairwise analysis to compare the following differences between the pandemic and the prepandemic periods: microbiologically confirmed central-line-associated bloodstream infection (CLABSI) and ventilator-associated pneumonia (VAP) incidence density (cases per 1,000 central line and ventilator days, respectively), the proportion of organisms that caused HAI, and antibiotic consumption (DDD). RESULTS: We detected a significant increase in median CLABSI incidence during the pandemic: 1.60 (IQR, 0.44-4.20) vs 2.81 (IQR, 1.35-6.89) (P = .002). We did not detect a significant difference in VAP incidence between the 2 periods. In addition, we detected a significant increase in the proportion of CLABSI caused by Enterococcus faecalis and Candida spp during the pandemic, although only the latter retained statistical significance after correction for multiple comparisons. We did not detect a significant change in ceftriaxone, piperacillin-tazobactam, meropenem, or vancomycin consumption between the studied periods. CONCLUSIONS: There was an increase in CLABSI incidence in Brazilian ICUs during the first months of COVID-19 pandemic. Additionally, we detected an increase in the proportion of CLABSI caused by E. faecalis and Candida spp during this period. CLABSI prevention strategies must be reinforced in ICUs during the COVID-19 pandemic.
Assuntos
COVID-19 , Infecções Relacionadas a Cateter , Infecção Hospitalar , Pneumonia Associada à Ventilação Mecânica , Adulto , Humanos , Pandemias , Infecções Relacionadas a Cateter/epidemiologia , Brasil/epidemiologia , Estudos Prospectivos , COVID-19/epidemiologia , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/microbiologia , Unidades de Terapia Intensiva , Hospitais , Pneumonia Associada à Ventilação Mecânica/epidemiologia , Pneumonia Associada à Ventilação Mecânica/microbiologia , Candida , Atenção à SaúdeRESUMO
The plasmid-mediated colistin-resistance gene named mcr-1 has been recently described in different countries and it became a public health challenge. Of note, few studies have addressed the spread of Escherichia coli harboring the mcr-1 gene in both, community and hospital settings. A total of seven colistin-resistant E. coli carrying mcr-1, collected from 2016 to 2018, from community (n=4), healthcare-acquired infections (n=2) and colonization (n=1) were identified in three high complexity hospitals in Sao Paulo, Brazil. These colistin-resistant isolates were screened for mcr genes by PCR and all strains were submitted to Whole Genome Sequencing and the conjugation experiment. The seven strains belonged to seven distinct sequence types (ST744, ST131, ST69, ST48, ST354, ST57, ST10), and they differ regarding the resistance profiles. Transference of mcr-1 by conjugation to E. coli strain C600 was possible in five of the seven isolates. The mcr-1 gene was found in plasmid types IncX4 or IncI2. Three of the isolates have ESBL-encoding genes (blaCTX-M-2, n=2; blaCTX-M-8, n=1). We hereby report genetically distinct E. coli isolates, belonging to seven STs, harboring the mcr-1 gene, associated to community and healthcare-acquired infections, and colonization in patients from three hospitals in Sao Paulo. These findings point out for the potential spread of plasmid-mediated colistin-resistance mechanism in E. coli strains in Brazil.
Assuntos
Colistina , Proteínas de Escherichia coli , Antibacterianos/farmacologia , Brasil , Colistina/farmacologia , Atenção à Saúde , Escherichia coli/genética , Proteínas de Escherichia coli/genética , Humanos , Testes de Sensibilidade MicrobianaRESUMO
Dropropizine is a peripheral antitussive drug that acts by inhibiting cough reflex through its action on the peripheral receptors and their afferent conductors. It is marketed in a racemic form or its pure enantiomer called levodropropizine and both are available worldwide in various drug dosage formulations such as tablets, sirup and oral solution. Due to the widespread use of antitussives in the clinic it is necessary to develop efficient analytical methodologies for quality control and also for pharmacokinetic, bioavailability and bioequivalence studies. This review presents a survey of the characteristics, properties and analytical methods used for drug determination, being carried out through scientific articles as well as in official compendia. From the analyzed studies, the majority reports the use of HPLC/UV techniques for drug determination, but also spectrophotometric UV/Vis methods as well as gas chromatography, and voltammetric, potentiometric and conductometric titration methods. In addition, the methodologies addressed the determination of dropropizine or levodropropizine in different types of matrices such as raw material, pharmaceutical formulations, plasma and urine. Despite the extensive clinical use of dropropizine, data from this review evidenced a still limited number of studies dealing with analytical methods for its determination in different matrices, which may be of concern since the applicability of these methods is important for quality assurance, efficacy and safety of the medicine.
Assuntos
Antitussígenos/análise , Cromatografia Líquida de Alta Pressão/métodos , Propilenoglicóis/análise , Antitussígenos/farmacocinética , Antitussígenos/uso terapêutico , Tosse/tratamento farmacológico , Cromatografia Gasosa-Espectrometria de Massas , Meia-Vida , Humanos , Propilenoglicóis/farmacocinética , Propilenoglicóis/uso terapêutico , Espectrofotometria , Estereoisomerismo , Comprimidos/químicaRESUMO
PURPOSE: To evaluate the effects of splenic ischemic preconditioning (sIPC) on oxidative stress induced by hepatic ischemia-reperfusion in rats. METHODS: Fifteen male Wistar rats were equally divided into 3 groups: SHAM, IRI and sIPC. Animals from IRI group were subjected to 45 minutes of partial liver ischemia (70%). In the sIPC group, splenic artery was clamped in 2 cycles of 5 min of ischemia and 5 min of reperfusion (20 min total) prior to hepatic ischemia. SHAM group underwent the same surgical procedures as in the remaining groups, but no liver ischemia or sIPC were induced. After 1h, hepatic and splenic tissue samples were harvested for TBARS, CAT, GPx and GSH-Rd measurement. RESULTS: sIPC treatment significantly decreased both hepatic and splenic levels of TBARS when compared to IRI group (p<0.01). Furthermore, the hepatic and splenic activities of CAT, GPx and GSH- Rd were significantly higher in sIPC group than in IRI group. CONCLUSION: sIPC was able to attenuate hepatic and splenic IRI-induced oxidative stress.
Assuntos
Precondicionamento Isquêmico/métodos , Hepatopatias/prevenção & controle , Fígado/irrigação sanguínea , Estresse Oxidativo/fisiologia , Traumatismo por Reperfusão/prevenção & controle , Animais , Modelos Animais de Doenças , Fígado/fisiologia , Hepatopatias/fisiopatologia , Masculino , Distribuição Aleatória , Ratos , Ratos Wistar , Traumatismo por Reperfusão/fisiopatologiaRESUMO
Purpose: To evaluate the effects of splenic ischemic preconditioning (sIPC) on oxidative stress induced by hepatic ischemia-reperfusion in rats. Methods: Fifteen male Wistar rats were equally divided into 3 groups: SHAM, IRI and sIPC. Animals from IRI group were subjected to 45 minutes of partial liver ischemia (70%). In the sIPC group, splenic artery was clamped in 2 cycles of 5 min of ischemia and 5 min of reperfusion (20 min total) prior to hepatic ischemia. SHAM group underwent the same surgical procedures as in the remaining groups, but no liver ischemia or sIPC were induced. After 1h, hepatic and splenic tissue samples were harvested for TBARS, CAT, GPx and GSH-Rd measurement. Results: sIPC treatment significantly decreased both hepatic and splenic levels of TBARS when compared to IRI group (p<0.01). Furthermore, the hepatic and splenic activities of CAT, GPx and GSH-Rd were significantly higher in sIPC group than in IRI group. Conclusion: sIPC was able to attenuate hepatic and splenic IRI-induced oxidative stress.(AU)
Assuntos
Animais , Masculino , Ratos , Insuficiência Hepática/complicações , Insuficiência Hepática/cirurgia , Isquemia/complicações , Isquemia/cirurgia , Reperfusão/métodos , Estresse Oxidativo , Precondicionamento Isquêmico/métodos , Ratos WistarRESUMO
BACKGROUND: Surgical site infections after cardiac surgery are associated with severe outcomes, including reoperation and death. We aimed to describe the effect of a standardized clinical-care protocol for preventing mediastinitis in patients who underwent coronary artery bypass graft surgery (CABG). METHODS: In a hospital certified by Joint Commission International, all patients who underwent CABG from January 2011 to December 2016 were compared in two periods according to the moment of implementation of a standardized clinical-care protocol for prevention of mediastinitis (CCPPM): pre-protocol (January 2011-December 2012) and post-protocol (January 2013-December 2016). The CCPPM consisted of the patient using a kit containing chlorhexidine 2% for bathing, mupirocin 20 mg/g for nasal topical use and chlorhexidine 0.12% for oral hygiene for 5 days before surgery, in addition to prophylaxis with a glycopeptide antimicrobial and strict glucose control (110-140 mg/dL) during surgery and immediate postoperative. RESULTS: We evaluated 1760 patients who underwent CABG in both periods. The occurrence of mediastinitis before protocol implementation was 1.44% (10 of 692 CABG). After the implementation of the protocol, there was an important reduction in the incidence of mediastinitis to 0.09% (1 of 1068 CABG) (P = 0.002). Although we did not observe a significant difference in mortality between the groups (2.3% vs 1%, P = 0.77), there was fewer in-hospital mortality due to mediastinitis after the CCPPM (0.2% vs 0%, P < 0.001). CONCLUSION: Implementation of a standardized CCPPM was associated with a significant reduction in the incidence of mediastinitis after CABG and reduction of mortality in the group of patients with mediastinitis.
Assuntos
Clorexidina/administração & dosagem , Ponte de Artéria Coronária , Hospitais Privados , Mediastinite/prevenção & controle , Assistência ao Paciente/métodos , Assistência ao Paciente/normas , Complicações Pós-Operatórias/prevenção & controle , Qualidade da Assistência à Saúde , Administração Tópica , Idoso , Antibioticoprofilaxia , Banhos , Feminino , Mortalidade Hospitalar , Humanos , Incidência , Masculino , Mediastinite/epidemiologia , Mediastinite/mortalidade , Pessoa de Meia-Idade , Mupirocina/administração & dosagem , Higiene Bucal , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/mortalidade , Fatores de TempoRESUMO
Abstract Purpose: To evaluate the effects of splenic ischemic preconditioning (sIPC) on oxidative stress induced by hepatic ischemia-reperfusion in rats. Methods: Fifteen male Wistar rats were equally divided into 3 groups: SHAM, IRI and sIPC. Animals from IRI group were subjected to 45 minutes of partial liver ischemia (70%). In the sIPC group, splenic artery was clamped in 2 cycles of 5 min of ischemia and 5 min of reperfusion (20 min total) prior to hepatic ischemia. SHAM group underwent the same surgical procedures as in the remaining groups, but no liver ischemia or sIPC were induced. After 1h, hepatic and splenic tissue samples were harvested for TBARS, CAT, GPx and GSH-Rd measurement. Results: sIPC treatment significantly decreased both hepatic and splenic levels of TBARS when compared to IRI group (p<0.01). Furthermore, the hepatic and splenic activities of CAT, GPx and GSH- Rd were significantly higher in sIPC group than in IRI group. Conclusion: sIPC was able to attenuate hepatic and splenic IRI-induced oxidative stress.
Assuntos
Animais , Masculino , Ratos , Traumatismo por Reperfusão/prevenção & controle , Estresse Oxidativo/fisiologia , Precondicionamento Isquêmico/métodos , Fígado/irrigação sanguínea , Hepatopatias/prevenção & controle , Traumatismo por Reperfusão/fisiopatologia , Distribuição Aleatória , Ratos Wistar , Modelos Animais de Doenças , Fígado/fisiologia , Hepatopatias/fisiopatologiaRESUMO
Background: The combination of delapril (DEL) and indapamide (IND) may be regarded as an optimal drug treatment for hypertensive patients. However, there is no published study concerning the suitable stability conditions and evaluation of drugs in the raw material and commercial product. Objective: The aim of the present study was to develop an innovative, high-throughput, and stability-indicating LC method for the simultaneous analysis of DEL and IND in combined dosage form. Methods: Analyses were performed using a core-shell C18 column (100 mm × 4.6 mm id, 2.6 µm) at 45°C using isocratic elution for the mobile phase composed of triethylamine solution (0.3%, pH 5.0)-acetonitrile-methanol (58 + 35 + 7, v/v/v). The separation was obtained within 3.5 min at a flow rate of 1.0 mL/min and UV detection set at 213 nm. Results: The specificity and stability-indicating capability of the method were proven through degradation studies, which also showed that there is no interference of the formulation excipients, showing that the peak is free from any co-eluting peak. Conclusions: The method showed adequate precision, with relative standard deviation values lower than 1.85%. Excellent values of accuracy were obtained, with a mean value of 98.64% for IND and 98.65% for DEL. Experimental design was used during validation to calculate and prove the method robustness. Highlights: The proposed LC method was successfully validated according to International Conference on Harmonisation requirements and applied for the simultaneous determination of DEL and IND in tablets, presenting suitability for stability studies and contributing to improve the QC of pharmaceuticals.
RESUMO
This study presents the development and validation of UV spectrophotometric methods for the determination of pinaverium bromide (PB) in tablet assay and dissolution studies. The methods were satisfactorily validated according to International Conference on Harmonization guidelines. The response was linear (r2 > 0.99) in the concentration ranges of 2-14 µg/mL at 213 nm and 10-70 µg/mL at 243 nm. The LOD and LOQ were 0.39 and 1.31 µg/mL, respectively, at 213 nm. For the 243 nm method, the LOD and LOQ were 2.93 and 9.77 µg/mL, respectively. Precision was evaluated by RSD, and the obtained results were lower than 2%. Adequate accuracy was also obtained. The methods proved to be robust using a full factorial design evaluation. For PB dissolution studies, the best conditions were achieved using a United States Pharmacopeia Dissolution Apparatus 2 (paddle) at 50 rpm and with 900 mL 0.1 M hydrochloric acid as the dissolution medium, presenting satisfactory results during the validation tests. In addition, the kinetic parameters of drug release were investigated using model-dependent methods, and the dissolution profiles were best described by the first-order model. Therefore, the proposed methods were successfully applied for the assay and dissolution analysis of PB in commercial tablets.
Assuntos
Morfolinas/análise , Morfolinas/química , Espectrofotometria Ultravioleta/métodos , Liberação Controlada de Fármacos , Limite de Detecção , Morfolinas/farmacocinética , Solubilidade , ComprimidosRESUMO
PURPOSE: In critical burn patients, the pharmacokinetic parameters (absorption, distribution, metabolism, and excretion) of many classes of drugs, including antibiotics, are altered. The aim of this study was to compare 2 groups of burn patients undergoing treatment for health care-associated infections with and without therapeutic drug monitoring. METHODS: A retrospective analysis of a clinical intervention (ie, a before/after study) was conducted with patients with health care-associated pneumonia, burn infection, bloodstream infection, and urinary tract infection in the burn intensive care unit of a tertiary care hospital. The patients were divided into 2 groups: (1) those admitted from May 2005 to October 2008 who received conventional antimicrobial dose regimens; and (2) those admitted from November 2008 to June 2011 who received antibiotics (imipenem, meropenem, piperacillin, and vancomycin) with doses adjusted according to plasma monitoring and pharmacokinetic modeling. General characteristics of the groups were analyzed, as were clinical outcomes and 14-day and in-hospital mortality. FINDINGS: Sixty-three patients formed the conventional treatment group, and 77 comprised the monitored treatment group. The groups were homogeneous, median age was 31 years (range: 1-90) and 66% were male. Improvement occurred in 60% of the patients under monitored treatment (vs 52% with conventional treatment); 14-day mortality was 16% vs 14%; and the in-hospital mortality was similar between groups (39% vs 36%). In the final multivariate models, variables significantly associated with in-hospital mortality were total burn surface area ≥30%, older age, and male sex. Treatment group did not affect the prognosis. IMPLICATIONS: Therapeutic drug monitoring of antimicrobial treatment did not alter the prognosis of these burn patients. More trials are needed to support the use of therapeutic drug monitoring to optimize treatment in burn patients.
Assuntos
Antibacterianos , Queimaduras , Monitoramento de Medicamentos , Infecções por Acinetobacter/sangue , Infecções por Acinetobacter/tratamento farmacológico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antibacterianos/sangue , Antibacterianos/farmacocinética , Antibacterianos/uso terapêutico , Bacteriemia/sangue , Bacteriemia/tratamento farmacológico , Queimaduras/sangue , Queimaduras/complicações , Queimaduras/tratamento farmacológico , Criança , Pré-Escolar , Infecção Hospitalar/sangue , Infecção Hospitalar/tratamento farmacológico , Feminino , Humanos , Imipenem/sangue , Imipenem/farmacocinética , Imipenem/uso terapêutico , Lactente , Unidades de Terapia Intensiva/estatística & dados numéricos , Masculino , Meropeném , Pessoa de Meia-Idade , Piperacilina/sangue , Piperacilina/farmacocinética , Piperacilina/uso terapêutico , Pneumonia/sangue , Pneumonia/tratamento farmacológico , Prognóstico , Centros de Atenção Terciária/estatística & dados numéricos , Tienamicinas/sangue , Tienamicinas/farmacocinética , Tienamicinas/uso terapêutico , Infecções Urinárias/sangue , Infecções Urinárias/tratamento farmacológico , Vancomicina/sangue , Vancomicina/farmacocinética , Vancomicina/uso terapêutico , Adulto JovemRESUMO
Abstract Introduction: Cerebrovascular accident (CVA) or stroke results in weakness of the trunk muscles and physical unfitness. Objectives: To evaluate respiratory changes caused by stroke and correlate them with the functional capacity of chronic stroke patients who were treated at the Clinical Center of Physical Therapy of the Pontifical Catholic University of Minas Gerais, Betim. Methods: Fifteen patients were recruited for assessment of respiratory function and functional capacity. We measured maximum inspiratory pressure (MIP), maximal expiratory pressure (MEP), peak expiratory flow (PEF), vital capacity (VC), and functional capacity using the six-minute walk test (6MWT). Test results were compared with reference values using an unpaired Student's t-test or the Mann-Whitney test. Respiratory variables were correlated with the distance walked in the 6MWT using Spearman's correlation test. Results: The sample had a mean age of 58.2 ± 13.4 years, and most patients had a diagnosis of ischemic stroke and left hemiparesis. The following values were obtained: MIP (47.7 ± 22.2 cmH2O); MEP (47.5 ± 20.3 cmH2O); PEF (351.3 ± 90.8 L/min); VC (3.0 ± 0.91 L); and 6MWT (222.4 ± 101.6 m). The MIP, MEP, PEF, and 6MWT values measured in this study were statistically significantly lower (p < 0.001) than the reference values. There was no statistically significant correlation between the distance walked in the 6 MWT and respiratory variables (p > 0.005). Conclusion: Our results suggest that, despite the decrease in respiratory muscle strength, PEF, and VC, these variables did not correlate with the functional capacity of the chronic stroke patients assessed in this study.
Resumo Introdução: O acidente vascular encefálico (AVE) resulta em fraqueza dos músculos do tronco e descondicionamento físico. Objetivos: Avaliar as alterações respiratórias e correlacioná-las com a capacidade funcional de pacientes pós AVE crônicos do Centro Clínico de Fisioterapia da PUC Minas Betim. Métodos: Foram recrutados 15 pacientes para avaliação respiratória e da capacidade funcional. Foram avaliadas a pressão inspiratória máxima (PImáx), pressão expiratória máxima (PEmáx), pico de fluxo expiratório (PFE), capacidade vital (CV) e a capacidade funcional a partir do teste de caminhada de seis minutos (TC6M). Os resultados foram comparados com os valores de referência utilizando os testes t de Student não pareado ou teste Mann-Whitney. As variáveis respiratórias foram correlacionadas com a distância percorrida no TC6M por meio do Coeficiente de Correlação de Spearman. Resultados: A amostra apresentou idade média de 58,2 ± 13,4 anos, sendo que o diagnóstico da maioria foi AVE isquêmico e hemiparesia à esquerda. Os valores obtidos foram PImáx (47,722,2 cmH2 O); PEmáx (47,5 20,3 cmH2 O); PFE (351,390,8 L/min); CV (3,00,91 L) e TC6m (222,4101,6 m). Quando comparados com os valores de referência, os valores de PImáx, PEmáx, PFE e TC6M foram estatisticamente menores (p < 0,001). Não houve correlação estatisticamente significativa entre a distância percorrida no TC6M e as variáveis respiratórias (p > 0,005). Conclusão: Os resultados sugerem que apesar de existir o declínio da força muscular respiratória, do PFE e da CV, esses não se correlacionaram com a capacidade funcional dos pacientes pós AVE crônicos avaliados.
RESUMO
Infection with carbapenem-resistant Acinetobacter baumannii (CRAB) after liver transplantation (LT) is associated with high mortality. This study aimed to identify risk factors for post-LT CRAB infection, as well as to evaluate the impact of pre-LT CRAB acquisition on the incidence of post-LT CRAB infection. This was a prospective cohort study of all patients undergoing LT at our facility between October 2009 and October 2011. Surveillance cultures (SCs) were collected immediately before LT and weekly thereafter, until discharge. We analyzed 196 patients who were submitted to 222 LTs. CRAB was identified in 105 (53.6%); 24 (22.9%) of these patients were found to have acquired CRAB before LT, and 85 (81.0%) tested positive on SCs. Post-LT CRAB infection occurred in 56 (28.6%), the most common site being the surgical wound. Multivariate analysis showed that the risk factors for developing CRAB infection were prolonged cold ischemia, post-LT dialysis, LT due to fulminant hepatitis, and pre-LT CRAB acquisition with pre-LT CRAB acquisition showing a considerable trend toward significance (P = 0.06). Among the recipients with CRAB infection, 60-day mortality was 46.4%, significantly higher than among those without (P < 0.001). Mortality risk factors were post-LT infection with multidrug-resistant bacteria, LT performed because of fulminant hepatitis, retransplantation, prolonged cold ischemia, longer LT surgical time, and pre-LT CRAB acquisition, the last showing a trend toward significance (P = 0.08). In conclusion, pre-LT CRAB acquisition appears to increase the risk of post-LT CRAB infection, which has a negative impact on recipient survival. Liver Transplantation 22 615-626 2016 AASLD.
Assuntos
Infecções por Acinetobacter/complicações , Antibacterianos/farmacologia , Carbapenêmicos/farmacologia , Farmacorresistência Bacteriana , Falência Hepática/complicações , Falência Hepática/cirurgia , Infecções por Acinetobacter/tratamento farmacológico , Acinetobacter baumannii/efeitos dos fármacos , Adolescente , Adulto , Idoso , Eletroforese em Gel de Campo Pulsado , Feminino , Humanos , Transplante de Fígado , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Complicações Pós-Operatórias , Estudos Prospectivos , Reoperação , Fatores de Risco , Fatores de Tempo , Resultado do Tratamento , Adulto JovemRESUMO
Este artigo tem por objetivo apresentar as pesquisas desenvolvidas no grupo ALTER-CNPq (LAEL - PUC-SP), destacando nossas contribuições a partir do Interacionismo Sociodiscursivo, da clínica da atividade e da ergonomia da atividade dos profissionais da educação, visando à construção de uma proposta nossa de análise das situações de trabalho educacional, a partir de alguns aspetos dessas teorias e de teorias coerentes entre si. Para tanto, traçaremos um breve histórico da evolução de nosso grupo de pesquisa e suas relações com as linhas teóricas já mencionadas; apresentaremos os pressupostos teóricos gerais em que nos apoiamos, assim como os autores que nos servem de base; exporemos nossos procedimentos de análise e os resultados que temos obtido; e, finalmente, discutiremos as contribuições de nosso trabalho, bem como as dificuldades que encontramos...
This paper aims at presenting the research that has been carried out by ALTER-LAEL Group, highlighting its contribution to the field of educational work based on Sociodiscursive Interactionism and on clinic of activity, in order to build a model of educational work analysis. firstly, we will present a brief history of the group evolution and its relations with the theoretical fields already mentioned; after that, we will explain the main concepts and the theoretical framework; then we will show the analysis procedures as well as the results obtained; finally, there is a discussion on the contributions and difficulties of the research...
Assuntos
Docentes , Ergonomia , Psicologia Educacional , TrabalhoRESUMO
Este artigo tem por objetivo apresentar as pesquisas desenvolvidas no grupo ALTER-CNPq (LAEL - PUC-SP), destacando nossas contribuições a partir do Interacionismo Sociodiscursivo, da clínica da atividade e da ergonomia da atividade dos profissionais da educação, visando à construção de uma proposta nossa de análise das situações de trabalho educacional, a partir de alguns aspetos dessas teorias e de teorias coerentes entre si. Para tanto, traçaremos um breve histórico da evolução de nosso grupo de pesquisa e suas relações com as linhas teóricas já mencionadas; apresentaremos os pressupostos teóricos gerais em que nos apoiamos, assim como os autores que nos servem de base; exporemos nossos procedimentos de análise e os resultados que temos obtido; e, finalmente, discutiremos as contribuições de nosso trabalho, bem como as dificuldades que encontramos.(AU)
This paper aims at presenting the research that has been carried out by ALTER-LAEL Group, highlighting its contribution to the field of educational work based on Sociodiscursive Interactionism and on clinic of activity, in order to build a model of educational work analysis. firstly, we will present a brief history of the group evolution and its relations with the theoretical fields already mentioned; after that, we will explain the main concepts and the theoretical framework; then we will show the analysis procedures as well as the results obtained; finally, there is a discussion on the contributions and difficulties of the research.(AU)
Assuntos
Ergonomia , Psicologia Educacional , Trabalho , DocentesRESUMO
JUSTIFICATIVA E OBJETIVOS: A síndrome dolorosa complexa regional (SDCR) é uma desordem do sistema nervoso central com disfunção simpática. Sua fisiopatologia não está esclarecida. Perifericamente há inflamação e hipóxia. A dor traz angústia para o paciente. O objetivo deste estudo foi relatar e avaliar o uso da lidocaína tópica a 4% durante a terapia ocupacional em pacientes ambulatoriais com SDCR. RELATO DOS CASOS: Foram estudados 5 pacientes, com idades acima de 18 anos, com SDCR tipo I e II de membro superior, avaliados em 6 consultas, com intervalos de 7 dias entre elas. Na primeira eram medicados com gabapentina e nas 5 posteriores a dose era aumentada. A partir da segunda consulta era utilizada a lidocaína a 4% tópica cerca de 30 minutos antes da realização dos exercícios de reabilitação do membro. Em 4 pacientes a SDCR era do tipo I. Em ordem decrescente os sintomas referidos foram: fisgada, queimação, alodínia, choque e parestesia. Todos os pacientes apresentavam edema e disfunção motora. Com a lidocaína tópica a 4% foi possível a realização dos exercícios orientados pelo terapeuta ocupacional, em regime ambulatorial, ocorrendo redução significativa da intensidade da dor. CONCLUSÃO: A lidocaína tópica a 4% permitiu a realização da reabilitação ocorrendo redução significativa da intensidade da dor.
BACKGROUND AND OBJECTIVES: Complex regional pain syndrome (CRPS) is a central nervous system disorder with sympathetic dysfunction. Its pathophysiology is not clear. There is peripheral inflammation and hypoxia. Pain distresses patients. These case reports aimed at evaluating topic 4% lidocaine during occupational therapy of outpatients with CRPS. CASE REPORTS: Participated in this study five patients aged above 18 years, with upper limb CRPS types I and II, who were evaluated in six visits with an interval of seven days. In the first, they were medicated with gabapentin and in the other five the dose was increased. As from the second visit, topic 4% lidocaine was applied approximately 30 minutes before rehabilitation exercises. Four patients had CRPS type I. In decreasing order, referred symptoms were: sting, burning, allodynia, shock and paresthesia. All patients had edema and motor dysfunction. Topic 4% lidocaine allowed patients to perform the exercises proposed by the occupational therapist, in outpatient regimen, with significant pain intensity improvement. CONCLUSION: Topic 4% lidocaine allowed rehabilitation with significant pain intensity improvement.
Assuntos
Humanos , Masculino , Feminino , Anestésicos Locais , Sistema Nervoso Central , Lidocaína , Terapia OcupacionalRESUMO
This paper presents the case of a 75-year-old Brazilian man who developed inflammatory skin lesions with nodules and ulcerations on the right forearm after an injury caused by handling barbed-wire and Eucalyptus spp. logs. Histopathological assessment of the lesions showed granulomatous processes with yeasts similar to Cryptococcus spp. Tissue fragments yielded yeasts when cultured that were identified as Cryptococcus gattii VGII through biochemical reactions and URA5-RFLP genotype. No evidence of systemic involvement or any underlying immunosuppressive diseases were identified, which supported the diagnosis of primary cutaneous cryptococcosis. After 5 months on therapy with high fluconazole doses, the skin lesions had fully healed.